Contact
Please use this form to send email to PR contact of this press release:
Ablexis Announces Perpetual License of the AlivaMab Mouse to Tri-Institutional Therapeutics Discovery Institute
TO:
Please use this form to send email to PR contact of this press release:
Ablexis Announces Perpetual License of the AlivaMab Mouse to Tri-Institutional Therapeutics Discovery Institute
TO: